Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
41 participants
INTERVENTIONAL
2005-02-28
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy
NCT05110391
Effects of a Fasting Mimicking Diet on Sperm Quality
NCT04908774
Use of Testicular Spermatozoa in Non-azoospermic Patients
NCT05203211
Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility
NCT02932865
Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome
NCT03129243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
testosterone injections
injections of testosterone to normal men (arm 1) and two men with subnormal semen parameters (arm 2)
injection of hormonal male contraceptive
testosterone injections 4 times
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
injection of hormonal male contraceptive
testosterone injections 4 times
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Muenster
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Muenster
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eberhard Nieschlag, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Institute of Reproductive Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Prof. Dr. Eberhard Nieschlag
Münster, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRM 2003/21
Identifier Type: -
Identifier Source: secondary_id
IRM 2003/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.